查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563126

全球放射肿瘤学市场：依类型、应用、最终用户和地区的预测（~2032年）

Global Radiation Oncology Market Research Report Information by Type, By Application, By End-User And by Region -Forecast Till 2032
出版日期: | 出版商: Market Research Future | 英文 176 Pages | 订单完成后即时交付

价格

放射肿瘤学市场规模将从2023年的82.3亿美元成长到2024年的89亿美元，预测期内年复合成长率为 8.0%，预计到2032年将成长到 165.1亿美元。全球癌症发生率的上升以及联合疗法（包括除手术和化疗外的放射肿瘤学）的接受度不断提高，推动市场扩张。

人口老化、生活方式改变和环境因素导致全球癌症发生率增加是市场的主要驱动力。调强放射治疗（IMRT）、立体定位放射外科（SRS）和质子治疗等放射治疗技术进步显着提高了治疗准确性和患者治疗效果，推动了市场成长。此外，日益使用联合疗法，包括化疗和手术之外的放射肿瘤学，也透过为患者提供更全面和有效的治疗选择来促进市场扩张。

癌症发生率的上升也是放射性肿瘤快速成长的主要动力。由于癌症发病率上升，全球对有效替代疗法的需求不断成长，因此市场日益扩大。

区域洞察

北美地区在2023年占据最高市场占有率，预计到2032年将达到约 72.4亿美元，预测期内年复合成长率为 8.2%。同时，亚太地区预计在预测期内将以8.4%的最高年复合成长率发展。

由于许多地区特定因素，北美放射肿瘤市场迅速扩大。北美癌症发生率的增加是一个重要的决定因素。随着生活方式的改变和老化导致癌症发生率增加，对放射肿瘤服务的需求也会增加。

在许多地区特定因素的推动下，欧洲放射肿瘤市场可望显着成长。整个欧洲癌症发生率的上升是一个重要的决定因素。癌症发生率上升增加了对放射治疗等先进治疗技术的需求。

在各种地区特定原因的推动下，亚太地区的放射肿瘤市场预计将显着成长。亚太地区癌症盛行率不断上升是重要因素。

本报告调查了全球放射肿瘤学市场，提供市场的定义和概述，市场成长的各种影响因素分析，市场规模推移和预测，各种区分、地区的细分，竞争环境，主要企业概况等彙整资料。

目次

第1章 执行摘要

第2章 市场概要

第3章 研究方法

第4章 市场力学

  • 促进要因
    • 癌症发生率增加
    • 放射治疗的技术进步
    • 除了手术和化疗外，还更多地采用包括放射肿瘤学在内的联合疗法
  • 课题
    • 监理审批挑战
    • 偿付问题
    • 缺乏熟练的放射治疗专家
  • 机会
    • 更重视基于价值的医疗保健和治疗解决方案
    • 人工智慧和机器学习在放射肿瘤学领域的应用越来越多

第5章 市场要因分析

  • 价值链分析
  • 波特五力分析
  • 新冠肺炎（COVID-19）影响分析

第6章 全球放射肿瘤学市场：依类型

  • 外部放射线治疗
    • 直线加速器
    • 钴60系统
    • 粒子束治疗系统
    • 质子束治疗系统
  • 内部放射线疗法
    • 种子
    • 后载入器
    • 术中放射治疗系统

第7章 全球放射肿瘤学市场：依应用分类

  • 摄护腺癌
  • 乳癌
  • 肺癌
  • 头颈癌
  • 其他

第8章 全球放射肿瘤学市场：依最终用户

  • 医院/诊所
  • 肿瘤中心
  • 学术研究所

第9章 全球放射肿瘤学市场：依地区

  • 世界
  • 北美
  • 欧洲
  • 亚太地区
  • 其他领域

第10章 竞合情势

  • 竞争仪表板
  • 市占率分析
  • 开发专案数量最多的公司
  • 主要公司列表：依国家/地区划分
  • 比较分析：主要公司的财务趋势
  • 主要发展与成长策略

第11章 公司简介

  • VARIAN MEDICAL SYSTEMS, INC.
  • ELEKTA
  • ACCURACY INCORPORATED
  • IBA RADIOPHARMA SOLUTIONS
  • BD
  • MEVION MEDICAL SYSTEMS
  • NORDION
  • NTP RADIOISOTOPES SOC LTD
  • CURIUM
  • REFLEXION
Product Code: MRFR/Pharma/10828-CR

Global Radiation Oncology Market Research Report Information by Type (External Beam Radiation Therapy and Internal Radiation Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck, and Others), By End-User (Hospitals & Clinics, Oncology Centers and Academic & Research Institutes) And by Region (North America, Europe, Asia-Pacific, and Rest of The World) -Forecast Till 2032

Market Overview

In 2023, the Radiation Oncology Market was valued at USD 8.23 billion. The market is expected to expand from USD 8.90 billion in 2024 to USD 16.51 billion by 2032, with a compound annual growth rate (CAGR) of 8.0% over the forecast period (2024-2032). The rising prevalence of cancer worldwide, as well as the growing acceptance of combination therapies that include radiation oncology in addition to surgery and chemotherapy, are driving market expansion.

The increased global prevalence of cancer, driven by aging populations, lifestyle changes, and environmental factors, is the primary driver of the radiation oncology industry. Technological advances in radiation therapy, including as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), and proton therapy, have significantly improved treatment accuracy and patient outcomes, driving market growth. Furthermore, the growing use of combination therapies that include radiation oncology in addition to chemotherapy and surgery helps to expand the market by giving patients with more comprehensive and productive treatment options.

The rising incidence of cancer has emerged as a major impetus for the rapid growth of radiation oncology. The radiation oncology market is expanding as a result of rising global demand for effective treatment alternatives in response to cancer's increasing prevalence.

Market Segment insights

The Radiation Oncology Market is divided into two product types: external beam radiation therapy and internal beam radiation therapy.

The Radiation Oncology Market has been segmented by price range into Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, and Others.

The market has been divided into three segments based on the end user: hospitals and clinics, oncology centers, and academic and research institutions.

Regional insights

The Radiation Oncology Market has been classified by region: North America, Europe, Asia-Pacific, and the Rest of the World. North America held the highest market share in 2023 and is expected to reach roughly USD 7.24 billion by 2032, growing at an 8.2% CAGR over the forecast period. However, Asia-Pacific is expected to develop at the fastest CAGR of 8.4% over the projection period.

The radiation oncology market in North America is rapidly expanding, driven by a number of unique regional variables. The increased incidence of cancer in North America is a key determinant. As cancer incidence rises due to lifestyle changes and an aging population, so does the demand for radiation oncology services.

The radiation oncology market in Europe is poised for significant growth, driven by a number of regionally specific reasons. The increased cancer incidence across Europe is a key determinant. The increasing prevalence of cancer has created a greater demand for sophisticated therapeutic techniques, such as radiation therapy.

The radiation oncology market in the Asia Pacific area is expected to grow significantly, driven by a variety of region-specific reasons. The increasing prevalence of cancer in the Asia-Pacific area is a significant factor.

Major Players

Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuracy Incorporated (US), IBA Radiopharma Solutions (Belgium), BD (US), Mevion Medical Systems (US), Nordion (Canada), NTP Radioisotopes Soc Ltd. (South Africa), Curium (France), and Reflexion (US) are among the key players in the Radiation Oncology Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 CONSUMPTION & NET TRADE APPROACH
    • 3.6.2 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 GROWING INCIDENCE OF CANCER
    • 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN RADIATION THERAPY
    • 4.2.3 RISING ADOPTION OF COMBINATION THERAPIES INVOLVING RADIATION ONCOLOGY ALONGSIDE SURGERY AND CHEMOTHERAPY
  • 4.3 CHALLENGES
    • 4.3.1 REGULATORY APPROVAL CHALLANGES
    • 4.3.2 REIMBURSEMENT CONCERNS
    • 4.3.3 LACK OF SKILLED RADIOTHERAPY PROFESSIONALS
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING EMPHASIS ON VALUE-BASED HEALTHCARE AND TREATMENT SOLUTIONS
    • 4.4.2 RISING UTILIZATION OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING WITHIN THE FIELD OF RADIATION ONCOLOGY

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 PARTICIPANTS (AT DIFFERENT NODES)
      • 5.1.1.1 RAW MATERIAL SUPPLIERS
      • 5.1.1.2 MANUFACTURERS
      • 5.1.1.3 DISTRIBUTION CHANNEL
      • 5.1.1.4 END-USER
    • 5.1.2 INTEGRATION LEVELS
    • 5.1.3 KEY ISSUES ADDRESSED (KEY SUCCESS FACTORS)
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF BUYERS
    • 5.2.3 THREAT OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT ANALYSIS OF COVID-19
    • 5.3.1 IMPACT ON OVERALL HEALTHCARE MARKET
      • 5.3.1.1 ECONOMIC IMPACT
    • 5.3.2 IMPACT ON GLOBAL RADIATION ONCOLOGY MARKET
    • 5.3.3 IMPACT ON MARKET DEMAND
      • 5.3.3.1 IMPACT DUE TO RESTRICTIONS/LOCKDOWN
      • 5.3.3.2 CONSUMER SENTIMENTS
    • 5.3.4 IMPACT ON PRICING

6 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 EXTERNAL BEAM RADIATION THERAPY
    • 6.2.1 LINEAR ACCELERATORS (LINAC)
      • 6.2.1.1 GAMMA KNIFE
      • 6.2.1.2 CYBERKNIFE
    • 6.2.2 COBALT-60 SYSTEM
    • 6.2.3 PARTICLE THERAPY SYSTEM
    • 6.2.4 PROTON BEAM THERAPY SYSTEM
  • 6.3 INTERNAL RADIATION THERAPY
    • 6.3.1 SEEDS
    • 6.3.2 AFTERLOADERS
    • 6.3.3 INTRAOPERATIVE RADIOTHERAPY SYSTEMS

7 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 PROSTATE CANCER
  • 7.3 BREAST CANCER
  • 7.4 LUNG CANCER
  • 7.5 HEAD & NECK
  • 7.6 OTHERS

8 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS & CLINICS
  • 8.3 ONCOLOGY CENTERS
  • 8.4 ACADEMIC & RESEARCH INSTITUTES

9 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 SOUTH KOREA
    • 9.4.5 AUSTRALIA
    • 9.4.6 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA
    • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 COMPETITION DASHBOARD
    • 10.2.1 PRODUCT PORTFOLIO
    • 10.2.2 REGIONAL PRESENCE
    • 10.2.3 STRATEGIC ALLIANCES
    • 10.2.4 INDUSTRY EXPERIENCES
  • 10.3 MARKET SHARE ANALYSIS, 2022
  • 10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL RADIATION ONCOLOGY MARKET
  • 10.5 LIST OF KEY PLAYERS, BY COUNTRY
  • 10.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
  • 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.7.1 PRODUCT LAUNCH
    • 10.7.2 PARTNERSHIP & COLLABORATION
    • 10.7.3 EXPANSION & ACQUISITION
    • 10.7.4 INVESTMENT

11 COMPANY PROFILES

  • 11.1 VARIAN MEDICAL SYSTEMS, INC.
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGY
  • 11.2 ELEKTA
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGY
  • 11.3 ACCURACY INCORPORATED
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGY
  • 11.4 IBA RADIOPHARMA SOLUTIONS
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGY
  • 11.5 BD
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 SWOT ANALYSIS
    • 11.5.5 KEY STRATEGY
  • 11.6 MEVION MEDICAL SYSTEMS
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 PRODUCTS OFFERED
    • 11.6.3 KEY DEVELOPMENTS
    • 11.6.4 SWOT ANALYSIS
    • 11.6.5 KEY STRATEGY
  • 11.7 NORDION
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 SWOT ANALYSIS
    • 11.7.6 KEY STRATEGY
  • 11.8 NTP RADIOISOTOPES SOC LTD
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 PRODUCTS OFFERED
    • 11.8.3 KEY DEVELOPMENTS
    • 11.8.4 SWOT ANALYSIS
    • 11.8.5 KEY STRATEGY
  • 11.9 CURIUM
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 PRODUCTS OFFERED
    • 11.9.3 KEY DEVELOPMENTS
    • 11.9.4 SWOT ANALYSIS
    • 11.9.5 KEY STRATEGY
  • 11.10 REFLEXION
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 PRODUCTS OFFERED
    • 11.10.3 KEY DEVELOPMENTS
    • 11.10.4 SWOT ANALYSIS
    • 11.10.5 KEY STRATEGY

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 3 GLOBAL RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 4 GLOBAL RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 5 GLOBAL RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 6 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 7 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 8 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 9 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 10 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 11 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 12 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 13 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 14 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 15 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 16 US RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 17 US RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 18 US RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 19 US RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 20 US RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 21 US RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 22 CANADA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 23 CANADA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 24 CANADA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 25 CANADA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 26 CANADA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 27 CANADA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 28 EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 1 EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 2 EUROPE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 3 EUROPE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 4 EUROPE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 5 EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 6 EUROPE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 7 GERMANY RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 8 GERMANY RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 9 GERMANY RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 10 GERMANY RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 11 GERMANY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 12 GERMANY RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 13 FRANCE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 14 FRANCE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 15 FRANCE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 16 FRANCE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 17 FRANCE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 18 FRANCE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 19 UK RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 20 UK RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 21 UK RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 22 UK RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 23 UK RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 24 UK RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 25 ITALY RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 26 ITALY RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 27 ITALY RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 28 ITALY RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 29 ITALY RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 30 ITALY RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 31 SPAIN RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 32 SPAIN RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 33 SPAIN RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 34 SPAIN RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 35 SPAIN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 36 SPAIN RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 37 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 38 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 39 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 40 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 41 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 42 REST OF EUROPE RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 43 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 44 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 45 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 46 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 47 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 48 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 49 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 50 CHINA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 51 CHINA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 52 CHINA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 53 CHINA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 54 CHINA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 55 CHINA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 56 JAPAN RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 57 JAPAN RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 58 JAPAN RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 59 JAPAN RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 60 JAPAN RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 61 JAPAN RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 62 INDIA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 63 INDIA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 64 INDIA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 65 INDIA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 66 INDIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 67 INDIA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 68 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 69 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 70 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 71 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 72 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 73 SOUTH KOREA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 74 AUSTRALIA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 75 AUSTRALIA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 76 AUSTRALIA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 77 AUSTRALIA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 78 AUSTRALIA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 79 AUSTRALIA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 80 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 81 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 82 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 83 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 84 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 85 REST OF ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 86 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 87 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 88 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 89 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 90 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 91 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 92 REST OF THE WORLD RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 93 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 94 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 95 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 96 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 97 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 98 MIDDLE EAST RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 99 AFRICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 100 AFRICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 101 AFRICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 102 AFRICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 103 AFRICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 104 AFRICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 105 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 106 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY EXTERNAL BEAM RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 107 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY LINEAR ACCELERATORS (LINAC), 2019-2032 (USD BILLION)
  • TABLE 108 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY INTERNAL RADIATION THERAPY, 2019-2032 (USD BILLION)
  • TABLE 109 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 110 LATIN AMERICA RADIATION ONCOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 111 PRODUCT LAUNCH
  • TABLE 112 PARTNERSHIP & COLLABORATION
  • TABLE 113 EXPANSION & ACQUISITION
  • TABLE 114 INSTRUMENT
  • TABLE 115 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
  • TABLE 116 ELEKTA: PRODUCTS OFFERED
  • TABLE 117 ACCURACY INCORPORATED: PRODUCTS OFFERED
  • TABLE 118 ACCURACY INCORPORATED: KEY DEVELOPMENTS
  • TABLE 119 IBA RADIOPHARMA SOLUTIONS: PRODUCTS OFFERED
  • TABLE 120 IBA RADIOPHARMA SOLUTIONS: KEY DEVELOPMENTS
  • TABLE 121 BD: PRODUCTS OFFERED
  • TABLE 122 MEVION MEDICAL SYSTEMS: PRODUCTS OFFERED
  • TABLE 123 MEVION MEDICAL SYSTEMS: KEY DEVELOPMENTS
  • TABLE 124 NORDION: PRODUCTS OFFERED
  • TABLE 125 NTP RADIOISOTOPES SOC LTD: PRODUCTS OFFERED
  • TABLE 126 CURIUM: PRODUCTS OFFERED
  • TABLE 127 REFLEXION: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL RADIATION ONCOLOGY MARKET: STRUCTURE
  • FIGURE 2 GLOBAL RADIATION ONCOLOGY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
  • FIGURE 5 SUPPLY CHAIN ANALYSIS: GLOBAL RADIATION ONCOLOGY MARKET
  • FIGURE 6 PORTER'S FIVE FORCES MODEL: GLOBAL RADIATION ONCOLOGY MARKET
  • FIGURE 7 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, SEGMENT ATTRACTIVENESS ANALYSIS
  • FIGURE 8 GLOBAL RADIATION ONCOLOGY MARKET, BY TYPE, 2022 (% SHARE)
  • FIGURE 9 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS
  • FIGURE 10 GLOBAL RADIATION ONCOLOGY MARKET, BY APPLICATION, 2022 (% SHARE)
  • FIGURE 11 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, SEGMENT ATTRACTIVENESS ANALYSIS
  • FIGURE 12 GLOBAL RADIATION ONCOLOGY MARKET, BY END USER, 2022 (% SHARE)
  • FIGURE 13 GLOBAL RADIATION ONCOLOGY MARKET, BY REGION, 2022 (% SHARE)
  • FIGURE 14 NORTH AMERICA MARKET: SWOT ANALYSIS
  • FIGURE 15 NORTH AMERICA RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE)
  • FIGURE 16 EUROPE RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE)
  • FIGURE 17 EUROPE MARKET: SWOT ANALYSIS
  • FIGURE 18 ASIA PACIFIC RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE)
  • FIGURE 19 ASIA PACIFIC MARKET: SWOT ANALYSIS
  • FIGURE 20 ROW RADIATION ONCOLOGY MARKET, BY COUNTRY, 2022 (% SHARE)
  • FIGURE 21 REST OF THE WORLD MARKET: SWOT ANALYSIS
  • FIGURE 22 COMPETITOR DASHBOARD: GLOBAL RADIATION ONCOLOGY MARKET
  • FIGURE 23 GLOBAL RADIATION ONCOLOGY MARKET: COMPETITIVE ANALYSIS, 2022
  • FIGURE 24 VARIAN MEDICAL SYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 25 VARIAN MEDICAL SYSTEMS, INC.: SWOT ANALYSIS
  • FIGURE 26 ELEKTA: SWOT ANALYSIS
  • FIGURE 27 ACCURACY INCORPORATED: SWOT ANALYSIS
  • FIGURE 28 IBA RADIOPHARMA SOLUTIONS: SWOT ANALYSIS
  • FIGURE 29 BD: SWOT ANALYSIS
  • FIGURE 30 MEVION MEDICAL SYSTEMS: SWOT ANALYSIS
  • FIGURE 31 NORDION: SWOT ANALYSIS
  • FIGURE 32 NTP RADIOISOTOPES SOC LTD: SWOT ANALYSIS
  • FIGURE 33 CURIUM: SWOT ANALYSIS
  • FIGURE 34 REFLEXION: SWOT ANALYSIS